Annual Report 2022

Annual Report 2022

18. Segment Reporting

The Company operates from the Netherlands, Belgium, the United States of America, Japan, Switzerland, Germany, France, Canada, UK, and Italy.

Following table summarizes our product net sales by country of sales based on the country of the entity that recognizes product net sales:

(in thousands of $)

 

Year Ended December 31, 2022

United States

 

377,659

Japan

 

15,764

Europe

 

5,678

Other 1)

 

1,619

Total product net sales

 

400,720

1)

The product net sales relates to sales made outside of the U.S., Japan and Europe and relates to named patient sale made with the U.S. label.

We sell our products through a limited number of distributors and wholesellers. Four U.S. customers represent approximately 91% of our product net sales in United States during twelve months ended December 31, 2022.

Collaboration revenue is generated by external customers with their main registered office geographically located as shown in the table below:

 

 

Year Ended December 31,

(in thousands of $)

 

2022

 

2021

 

2020

Denmark

 

5,365

 

1,389

 

342

Belgium

 

 

 

United States

 

 

317,396

 

40,901

China

 

4,238

 

178,370

 

Other

 

424

 

123

 

Total collaboration revenue

 

10,026

 

497,277

 

41,243

The non-current assets of the Company, with the exception of the deferred tax assets, are geographically located as shown in the table below:

 

 

At December 31,

(in thousands of $)

 

2022

 

2021

 

2020

Netherlands

 

 

 

1

Belgium

 

275,620

 

268,733

 

200,125

United States

 

2,325

 

3,138

 

4,751

Japan

 

2,763

 

3,232

 

2,491

Switzerland

 

 

8

 

Germany

 

130

 

 

France

 

4

 

 

Total

 

280,841

 

275,111

 

207,368